AZD9592: Data from P1 EGRET trial (NCT05647122) for advanced solid tumors/NSCLC/HNSCC in 2025 (AstraZeneca) - Feb 28, 2024 - Q4 & FY2023 Results
P1 data • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck
|